Cullen/Frost Bankers’s Bio-Techne TECH Stock Holding History

Cullen/Frost Bankers’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-68	Closed	-$5.43K	–	1445
2024 Q3	$5.43K	Buy	+68	New	+$5.11K	﹤0.01%	983
2023 Q3	–	Sell	-400	Closed	-$32.7K	–	1199
2023 Q2	$32.7K	Hold	400	–	–	﹤0.01%	794
2023 Q1	$29.7K	Hold	400	–	–	﹤0.01%	801
2022 Q4	$33.2K	Hold	400	–	–	﹤0.01%	762
2022 Q3	$28K	Buy	400 +332	+488%	+$28.7K	﹤0.01%	803
2022 Q2	$6K	Hold	68	–	–	﹤0.01%	953
2022 Q1	$7K	Hold	68	–	–	﹤0.01%	981
2021 Q4	$9K	Sell	68 -1,332	-95%	-$163K	﹤0.01%	981
2021 Q3	$170K	Hold	1,400	–	–	﹤0.01%	551
2021 Q2	$158K	Buy	1,400 +1,332	+1,959%	+$140K	﹤0.01%	569
2021 Q1	$6K	Buy	+68	New	+$6.2K	﹤0.01%	972
2020 Q3	–	Sell	-68	Closed	-$5K	–	1267
2020 Q2	$5K	Hold	68	–	–	﹤0.01%	966
2020 Q1	$3K	Hold	68	–	–	﹤0.01%	839
2019 Q4	$4K	Hold	68	–	–	﹤0.01%	969
2019 Q3	$3K	Sell	68 -264	-80%	-$13.2K	﹤0.01%	955
2019 Q2	$17K	Buy	332 +264	+388%	+$13.3K	﹤0.01%	736
2019 Q1	$3K	Buy	+68	New	+$3.06K	﹤0.01%	838

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Cullen/Frost Bankers's TECH Position: Q4 2024 in Review

Cullen/Frost Bankers sold out of Bio-Techne (TECH) in Q4 2024, closing a stake of 68 shares — an estimated $5.43K sold.

Cullen/Frost Bankers first reported a position in TECH in Q1 2019 and held it in 17 quarters. The position peaked at $170K in Q3 2021. 577 funds tracked by Wall St. Rank hold TECH as of Q4 2024.

Cullen/Frost Bankers reported no remaining Bio-Techne position as of Q4 2024 after selling out during the quarter.
Cullen/Frost Bankers sold 68 Bio-Techne shares in Q4 2024, an estimated $5.43K.
Cullen/Frost Bankers first reported a position in Bio-Techne in Q1 2019 and held it in 17 quarters.
Cullen/Frost Bankers's Bio-Techne position peaked at $170K in Q3 2021.
577 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2024.

Based on Cullen/Frost Bankers's 13F filing for Q4 2024, filed 6 Feb 2025.